An alternative strategy to limit negative regulation of T cell function and to break immunotolerance to tumor cells involves the modulation of L-tryptophan metabolism via the kynurenine pathway with the indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor epacadostat [98]. Here, IDO1 is linked to neoplasm.